mad-overexpression down regulates the malignant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells
- 1 March 1999
- journal article
- Published by Springer Nature in Cell Research
- Vol. 9 (1) , 51-59
- https://doi.org/10.1038/sj.cr.7290005
Abstract
Mad protein has been shown as an antagonist of c-Mycprotein in some cell lines. The effect of Mad protein to the malignant phenotype of human hepatoma BEL-7404 cell line was investigated experimentally. An eukarryotic vector pCDNA III containing full ORF fragment of mad cDNA was transfected into targeted cells. Under G418 selection, stable Mad-overexpressed cells were cloned. Studies on the effect of Mad over-expression in cell proliferation and cell cycle revealed that cell morphology of the Mad-overexpressed BEL-7404-M1cells was significantlydifferent from the parent and control vector transfected cells. DNA synthesis, cell proliferation and anchorage-independent growth in soft-agar of the mad-transfected cells were partially inhibited in comparison to control cells. Flow Cytometry analysis indicated that mad over-expression might block more transfectant cells at G0/G1 phase, resulting in the retardation of cell proliferation. RT-PCR detected a marked inhibition of the expression of cdc25A, an important regulator gene of G0/G1 to S phase in cell cycle. It was also found that Mad protein overexpression could greatly suppress p53-mediated apoptosis in BEL-7404-M1 cells in the absence of serume. Thus, Mad proteins may function as a negative regulator antagonizing c-Myc activity in the control of cell growth and apoptosis in human hepatocellular carcinoma BEL-7404. cellsKeywords
This publication has 14 references indexed in Scilit:
- Cdc25 cell-cycle phosphatase as a target of c-mycNature, 1996
- Proteins of the Myc Network: Essential Regulators of Cell Growth and DifferentiationPublished by Elsevier ,1996
- Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cellsNature Medicine, 1995
- Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and deathCurrent Opinion in Genetics & Development, 1994
- A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.Genes & Development, 1993
- THE TUMOR SUPPRESSOR GENESAnnual Review of Biochemistry, 1993
- Oncogenic activity of the c-Myc protein requires dimerization with MaxCell, 1993
- Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sitesCell, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991